OPKO Health Inc. Logo

OPKO Health Inc.

Provides clinical diagnostics & develops novel therapies for serious & pediatric diseases.

OPK | TA

Overview

Corporate Details

ISIN(s):
US68375N1037
LEI:
Country:
Israel
Address:
4400 Biscayne Blvd., 33137 Miami
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

OPKO Health, Inc. is a diversified and fully-integrated healthcare company operating in the diagnostics and pharmaceuticals sectors. Its diagnostics division features BioReference Laboratories, one of the largest full-service clinical reference laboratories in the U.S. The pharmaceuticals division focuses on discovering, developing, and commercializing novel therapies for serious diseases. Key marketed products include NGENLA™, a next-generation human growth hormone therapy for pediatric patients, and RAYALDEE®. The company's research pipeline is centered on advancing multispecific therapies for conditions like cancer and infectious diseases, supported by strategic partnerships with leading pharmaceutical and scientific organizations such as Pfizer and Merck.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-23 10:43
Regulatory News Service
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Phillip Frost…
Hebrew (modern) 83.1 KB
2025-11-23 10:43
Foreign Filer Report
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Phillip Frost…
English 36.3 KB
2025-11-23 10:43
Director's Dealing
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Phillip Frost…
English 84.7 KB
2025-11-23 10:43
Foreign Filer Report
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Phillip Frost…
English 36.3 KB
2025-11-20 10:22
Regulatory News Service
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Phillip Frost…
Hebrew (modern) 85.7 KB
2025-11-20 10:22
Foreign Filer Report
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Phillip Frost…
English 36.3 KB
2025-11-20 10:20
Regulatory News Service
OPKO Health to participate in the Piper Sandler 37th Annual Healthcare Conferen…
Hebrew (modern) 157.4 KB
2025-11-20 10:20
Foreign Filer Report
OPKO Health to participate in the Piper Sandler 37th Annual Healthcare Conferen…
English 36.4 KB
2025-11-19 10:38
Director's Dealing
FORM 4 - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- PHILLIP FR…
English 88.0 KB
2025-11-19 10:38
Foreign Filer Report
FORM 4 - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- PHILLIP FR…
English 36.3 KB
2025-11-02 00:00
Director's Dealing
Immediate Report
English 83.2 KB
2025-11-02 00:00
Foreign Filer Report
Immediate Report
English 36.3 KB
2025-10-30 00:25
Quarterly Report
Report of Periodic or Interim Report
English 1.4 MB
2025-10-30 00:25
Foreign Filer Report
Report of Periodic or Interim Report
English 36.6 KB
2025-10-30 00:23
Earnings Release
Immediate Report
English 1.4 MB

Automate Your Workflow. Get a real-time feed of all OPKO Health Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for OPKO Health Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for OPKO Health Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden
2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom
4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America
SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America
AARD
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America
ABBV
ABEONA THERAPEUTICS INC. Logo
Developing AAV-based cell and gene therapies for serious and rare diseases.
United States of America
ABEO
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden
ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom
ABDX

Talk to a Data Expert

Have a question? We'll get back to you promptly.